MedTrace Logo

Clinical Comparative Trial of a Modified Polyurethane Dressing and Aquacel

NCT01055925 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2010-01-26

No results posted yet for this study

Summary

The almost single disadvantage of conventional polyurethane film dressings, an uncontrolled leakage, is probably as often described as its numerous advantages for split-thickness skin graft (STSG) donor sites. This shortcoming can be overcome by perforating the polyurethane dressing (MPD), which permits a controlled leakage into a secondary absorbent dressing. The study was conducted to compare the MPD-system and Aquacel® (ConvaTec), a hydrofiber wound dressing, which also seems to fulfill all criteria of an ideal donor site dressing.

Conditions

  • Reepithelialization of Skin Graft Donor Sites

Interventions

DEVICE

modified polyurethane film dressing (OpSite, Smith&Nephew, London, UK)

DEVICE

Aquacel® (ConvaTec, Skillman, NJ, USA), sodium carboxy-methylcellulose hydrocolloid polymer dressing

Sponsors & Collaborators

  • Klinik Bogenhausen

    lead OTHER

Study Design

Purpose
TREATMENT

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01055925 on ClinicalTrials.gov